Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with HCV-related cirrhosis

2018; Elsevier BV; Volume: 50; Issue: 1 Linguagem: Inglês

10.1016/j.dld.2018.01.009

ISSN

1878-3562

Autores

Chiara Masetti, Raffaella Lionetti, M. Lupo, Massimo Siciliano, Valerio Giannelli, Francesca Romana Ponziani, Elisabetta Teti, Chiara Dell’Unto, S. Francioso, A. Brega, Marzia Montalbano, Ubaldo Visco‐Comandini, Chiara Taibi, Giovanni Galati, Umberto Vespasiani‐Gentilucci, Antonio Picardi, Massimo Andreoni, Maurizio Pompili, Adriano Pellicelli, Gianpiero D’Offizi, Antonio Gasbarrini, A. De Santis, M. Angélico,

Tópico(s)

Liver Disease and Transplantation

Resumo

Background and aims: Residual risk of HCC in HCV-infected cirrhotic patients treated with DAA is still debated. We investigated this issue in a large cohort of cirrhotic patients treated in 7 hospitals.

Referência(s)